Symbol | Exchange | Currency |
|---|
Investing.com – U.S. stocks were mixed after the close on Friday, as gains in the Oil & Gas, Telecoms and Financials sectors led shares higher while losses in the Technology,...
C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins for the treatment of cancer, neurodegenerative conditions, and other diseases. Its lead product candidate is CFT7455, an orally bioavailable MonoDAC degrader of protein that is in Phase 1/2 trial targeting IKZF1 and IKZF3 for multiple myeloma and non-Hodgkin lymphomas, including peripheral T-cell lymphoma and mantle cell lymphoma. The company is also developing CFT8634, an orally bioavailable BiDAC degrader of BRD9, a protein target for synovial sarcoma and SMARCB1-deleted solid tumors; CFT1946, an orally bioavailable BiDAC degrader targeting V600X mutant BRAF to treat melanoma, non-small cell lung cancer (NSCLC), colorectal cancer, and other solid malignancies; CFT8919, an orally bioavailable, allosteric, and mutant-selective BiDAC degrader of epidermal growth factor receptor, or EGFR, with an L858R mutation in NSCLC; and earlier stage programs comprising RET degraders for the treatment of various cancers. C4 Therapeutics, Inc. has strategic collaborations with F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc.; Biogen MA, Inc.; and Calico Life Sciences LLC. The company was incorporated in 2015 and is headquartered in Watertown, Massachusetts.
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Buy | Strong Buy | Strong Buy | Buy | Strong Sell |
| Technical Indicators | Strong Buy | Strong Buy | Strong Buy | Buy | Strong Sell |
| Summary | Strong Buy | Strong Buy | Strong Buy | Buy | Strong Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 0.99 | 1.33 | 0.91 | +0.150 | +17.86% | 101.76M | NASDAQ | |||
| 184.64 | 186.79 | 178.50 | -6.01 | -3.15% | 3.00M | NASDAQ | |||
| 7.54 | 7.87 | 7.39 | -0.18 | -2.33% | 5.04M | NYSE | |||
| 35.31 | 37.45 | 35.22 | -1.29 | -3.52% | 6.55M | NYSE | |||
| 47.76 | 49.51 | 47.28 | -0.80 | -1.65% | 1.97M | NYSE | |||
| 4.44 | 4.47 | 4.44 | 0.000 | 0.00% | 0.00 | NYSE | |||
| 0.1265 | 0.1276 | 0.1218 | +0.0015 | +1.20% | 2.27M | NYSE | |||
| 1.00 | 1.0588 | 0.98 | -0.0500 | -4.76% | 6.86M | NYSE | |||
| 1.43 | 1.45 | 1.37 | +0.010 | +0.70% | 5.35M | NASDAQ | |||
| 2,245.13 | 2,273.29 | 2,231.08 | -6.30 | -0.28% | 912.62K | NASDAQ | |||
| 92.32 | 94.10 | 91.60 | -0.61 | -0.66% | 1.05M | NASDAQ | |||
| 0.626 | 0.679 | 0.589 | -0.027 | -4.09% | 1.63M | NASDAQ | |||
| 112.55 | 113.30 | 110.37 | +1.54 | +1.39% | 839.29K | NYSE | |||
| 17.29 | 17.56 | 17.25 | -0.18 | -1.03% | 3.77M | NYSE | |||
| 24.93 | 25.30 | 24.83 | -0.38 | -1.48% | 219.58K | OTC Markets |